Skip to main content
Sadhana Nitrochem Ltd. logo

Sadhana Nitrochem Ltd. — Investor Relations & Filings

Ticker · SADHNANIQ ISIN · INE888C01040 BSE.NS Manufacturing
Open in API
Filings indexed 837 across all filing types
Latest filing 2023-10-19 Regulatory Filings
Country IN India
Listing BSE.NS SADHNANIQ

About Sadhana Nitrochem Ltd.

https://www.sncl.com

Sadhana Nitrochem Ltd. specializes in the manufacture of chemical intermediates and performance chemicals. The company's core product portfolio includes nitrobenzene and its downstream derivatives such as metanilic acid, aniline 2,5 disulphonic acid, and sodium meta nitrobenzene sulphonate. These products serve as critical raw materials for the global dyes, pigments, pharmaceuticals, and agrochemicals sectors. The company operates advanced manufacturing facilities focused on high-purity chemical synthesis and process optimization. Its technical capabilities extend to specialized chemical reactions including nitration, hydrogenation, and sulfonation. By maintaining a vertically integrated production model, the company ensures consistent quality and supply chain reliability for its international client base across various industrial applications.

Recent filings

Filing Released Lang Actions
Change in Management
Regulatory Filings Classification · 95% confidence The document is extremely short (384 characters) and consists solely of digital signature information without any substantive content related to financial performance, management changes, or other reportable events. There is no indication of a report, announcement, or detailed information. Given the lack of content and the presence of digital signatures only, this document fits best as a Regulatory Filing (RNS), which serves as a fallback category for miscellaneous filings that do not fit other specific categories.
2023-10-19 English
Change in Director(s)
Regulatory Filings Classification · 100% confidence The document text is extremely short (384 characters) and consists solely of digital signature information without any substantive content related to financial performance, management changes, or other report details. There is no indication of a full report or detailed financial data. This matches the pattern of an officer certification or attestation document. According to the CERTIFICATION RULE, such documents should be classified as Regulatory Filings (RNS).
2023-10-19 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a formal notification addressed to stock exchanges about an upcoming Board Meeting scheduled for October 26, 2023. The purpose of the meeting is to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2023. The document also mentions the closure of the trading window for insiders in compliance with SEBI regulations. The document does not contain the financial results themselves but is an announcement of the meeting where these results will be approved. The document length is short (1850 characters), and it serves as an intimation rather than the actual financial report. Therefore, it fits the category of a Regulatory Filing (RNS) as a general regulatory announcement and notification to exchanges about board meetings and financial results approval.
2023-10-18 English
Board Meeting — SADHANA NITROCHEM LIMITED has informed the Exchange about Board Meeting to be held on 26-Oct-2023 to inter-alia consider and approve the Unaudited Financial results of the Company for…
Regulatory Filings
2023-10-18 English
SADHANA NITROCHEM LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/10/2023 ,inter alia, to consider and approve Unaudited Standalone and ....
Board/Management Information Classification · 95% confidence The document is a notification to stock exchanges about an upcoming Board Meeting scheduled for October 26, 2023. The purpose of the meeting is to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2023. It also mentions the closure of the trading window for insiders as per SEBI regulations. The document is short (1850 characters) and serves as an announcement of a future event and financial results approval, not the financial results report itself. Therefore, it is an announcement related to board/management activities and regulatory compliance rather than a full financial report or earnings release. The best fitting category is Board/Management Information (MANG).
2023-10-18 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, confirming dematerialization of securities for the quarter ended September 30, 2023. It includes detailed tables of demat/remat requests received and released during the quarter. The document is a regulatory compliance certificate related to securities dematerialization, not a financial report or earnings release. It is not an announcement of a report but a compliance certificate with supporting data. Therefore, it fits best under Regulatory Filings (RNS) as it is a regulatory compliance document and does not contain financial statements or management discussion.
2023-10-13 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.